BRIEF—Juno Pharma acquires Omega Labs

Juno Pharmaceuticals Canada has purchased Omega Laboratories, a  specialist injectable pharmaceutical manufacturer in Canada, for an undisclosed sum.

The merged entity represents one of the biggest specialist generic injectable operations in Canada with local manufacturing facilities.

It will benefit from Omega’s newly-opened injectable manufacturing facility, which has received clearances from Health Canada and the US Food and Drug Administration, as well as from Juno’s commercial network and product development pipeline.

The firm plans to offer more than 100 new products to the Canadian market in the next four years, with pain management, oral solutions, allergy vaccines, diabetes and weight loss as the main areas of focus.